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Muscular dystrophies are a heterogeneous group of genetically inherited disorders whose
most prominent clinical feature is progressive degeneration of skeletal muscle. In several
forms of the disease, the function of cardiac muscle is likewise affected. The primary
defect in this group of diseases is caused by mutations in myocyte proteins important
to cellular structure and/or performance. That being stated, a growing body of evidence
suggests that the development of autonomic dysfunction may secondarily contribute
to the generation of skeletal and cardio-myopathy in muscular dystrophy. Indeed,
abnormalities in the regulation of both sympathetic and parasympathetic nerve activity
have been reported in a number of muscular dystrophy variants. However, the
mechanisms mediating this autonomic dysfunction remain relatively unknown. An
autonomic reflex originating in skeletal muscle, the exercise pressor reflex, is known to
contribute significantly to the control of sympathetic and parasympathetic activity when
stimulated. Given the skeletal myopathy that develops with muscular dystrophy, it is logical
to suggest that the function of this reflex might also be abnormal with the pathogenesis
of disease. As such, it may contribute to or exacerbate the autonomic dysfunction that
manifests. This possibility along with a basic description of exercise pressor reflex function
in health and disease are reviewed. A better understanding of the mechanisms that
possibly underlie autonomic dysfunction in muscular dystrophy may not only facilitate
further research but could also lead to the identification of new therapeutic targets for
the treatment of muscular dystrophy.
Keywords: sympathetic nerve activity, parasympathetic nerve activity, cardiovascular disease, muscle afferents,
muscular dystrophy, exercise
INTRODUCTION
Muscular dystrophies (MD) are a group of debilitating, incur-
able, and often lethal disorders that present with many of the
same pathological features (Emery, 2002). A shared characteris-
tic is the development of progressive skeletal muscle degeneration
and weakness whose distribution can often be used to distin-
guish between the many forms of the disease (Duchenne, Becker,
limb girdle, facioscapulohumeral, Emery-Dreifuss, myotonic dys-
trophy, etc.) (Emery, 1998). Involvement of respiratory muscles
and the development of reduced ventilatory function is likewise
a common feature with the distribution, progression, and sever-
ity varying greatly among the different dystrophies (Mercuri and
Muntoni, 2013). Cardiac and smooth muscle can also be affected
with the former manifesting as dilated cardiomyopathies and/or
conduction defects and the latter presenting as problems with
gastric emptying and/or urinary retention, for example (Yilmaz
and Sechtem, 2012; Mercuri and Muntoni, 2013). The primary
defect in the various muscular dystrophies involves mutations
of myocyte proteins important to cellular structure and/or func-
tion. These include, but are not limited to, extracellular matrix
and external membrane proteins, proteins associated with the sar-
colemma, sarcomeric proteins, nuclear membrane proteins and
enzymatic proteins (Mercuri and Muntoni, 2013). Despite this
knowledge, the various factors that mediate the development of
end-organ damage in the muscular dystrophies is not fully under-
stood and represents an area of continued intense investigation.
In this regard, the development of autonomic dysfunction in MD
has received considerable attention recently.
AUTONOMIC DYSFUNCTION IN MUSCULAR DYSTROPHY
In addition to the primary muscular defects, another possible
contributor to the generation of pathology in muscular dystro-
phy is the genesis of autonomic dysfunction. Impairments of the
autonomic nervous system have been described in patients with
Duchenne and Becker MD (Politano et al., 2008). In both types of
MD, an autonomic imbalance has been observed in which sympa-
thetic activity is significantly increased coupled with diminished
parasympathetic activity (Yotsukura et al., 1995; Lanza et al.,
2001; Inoue et al., 2009). It has been speculated that such an
imbalance may contribute to the development of dilated car-
diomyopathy, ventricular arrhythmias, and sudden cardiac death
in these patients (Ducceschi et al., 1997). In themdxmousemodel
of MD, a model mimicking the abnormality found in patients
with Duchenne MD (i.e., deficiency of the cytoskeletal protein
dystrophin), pharmacological autonomic blockade and barore-
flex sensitivity testing have likewise demonstrated an imbalance
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in the autonomic regulation of heart rate being characterized by
enhancements and decrements in sympathetic and parasympa-
thetic activity, respectively (Chu et al., 2002). Similar findings
have been reported in patients with facioscapulohumeral MD
(DellaMarca et al., 2010). Autonomic abnormalities of vary-
ing degrees have likewise been reported in myotonic dystrophy
(Inoue et al., 1995; DiLeo et al., 2004) as well as Emery-Dreifuss
(Fujita et al., 2005), Fukuyama Congenital (Itoh et al., 1996), and
Miyoshi MDs (Tomoda et al., 1994).
To date, most studies have focused on the impact autonomic
dysfunction has on cardiac performance and morphology in MD
with little attention given to its possible role in the development
of skeletal myopathy (the primary pathology). Indeed, the auto-
nomic nervous system is intimately involved in the control of
blood flow to skeletal muscle via its modulation of cardiac out-
put, blood pressure, and vascular resistance (Mitchell et al., 1994).
Alterations in the ability of the autonomic nervous system to ade-
quately regulate these hemodynamic variables could significantly
compromise blood flow to peripheral skeletal muscle initiating
and/or exacerbating the primary degenerative processes charac-
teristic of the disease. As an example, normally during exercise
sympathetic activity is increased while parasympathetic activ-
ity is largely withdrawn. As a result, cardiac output is enhanced
and the resistance to blood flow in the visceral organs and non-
contracting skeletal muscle is elevated. In contrast, sympathetic
vasoconstriction is opposed in active skeletal muscle by local
metabolic vasodilation (i.e., functional sympatholysis) augment-
ing blood flow (Remensnyder et al., 1962). In this way, autonomic
modulation of the cardiovascular system closely matches the
delivery of blood to meet the metabolic demands of the working
muscle. In an elegant series of studies in patients with dys-
trophinopathies (Duchenne and Becker MD) as well as mouse
models of the disorder, it has been repeatedly demonstrated that
the metabolic modulation of sympathetic vasoconstriction in
working skeletal muscle is impaired producing ischemia during
exercise (Thomas et al., 1998; Sander et al., 2000; Lai et al., 2009;
Martin et al., 2012). The studies indicate that this impaired func-
tion is largely due to the loss of sarcolemmal neuronal nitric oxide
synthase which is requisite to produce the nitric oxide necessary
to mitigate α-adrenergic vasoconstriction (Thomas et al., 1998;
Sander et al., 2000). It has been suggested that repeated bouts
of ischemia in these patients, which could occur in the perfor-
mance of routine daily activities, may initiate and/or accelerate
fiber necrosis in the muscle (Sander et al., 2000; Ito et al., 2006).
Potentially, this could facilitate the early onset of muscle fatigue,
limit exercise tolerance, and at the same time promote muscle
degeneration (Thomas et al., 1998). Although these studies do
not directly infer autonomic dysfunction but rather the inability
to oppose sympathetic activity, they do demonstrate the potential
impact abnormal alterations in sympathetic and parasympathetic
activity during exercise may have on the regulation of skeletal
muscle blood flow and, potentially, the generation of skeletal
myopathy in MD.
AUTONOMIC REGULATION DURING EXERCISE
Although in certain forms of MD physical activity is limited
from birth, decrements in the ability to exercise present later
(childhood, adolescence, adulthood) in other forms of the dis-
ease (Mercuri and Muntoni, 2013). In patients that do maintain
the ability to perform exercise, even when limited, the develop-
ment of autonomic dysfunction during physical activity could
have a considerable impact on the generation of both cardiac
and skeletal muscle abnormalities. Therefore, it is important to
understand the mechanisms underlying the autonomic response
to exercise. To this end, autonomic function is regulated by input
from three distinct neural mechanisms during exercise: central
command, the baroreflex (arterial and cardiopulmonary) and the
exercise pressor reflex. Central command has been described as a
feed-forward mechanism from higher brain centers involving the
parallel activation of motor neurons for volitional movement and
autonomic circuits within the brainstem (Goodwin et al., 1972).
The baroreflex, with receptors located in the carotid sinuses
and aortic arch (arterial baroreflex) as well as the heart and
lungs (cardiopulmonary baroreflex), is a negative feedback system
that modulates moment-to-moment variations in blood pressure
by continually adjusting autonomic activity (Mancia and Mark,
1983; Mark and Mancia, 1983). The exercise pressor reflex (EPR)
is a peripheral feedback input emanating from skeletal muscle
that likewise transmits signals to autonomic centers within the
brainstem (McCloskey and Mitchell, 1972). Collectively, these
inputs mediate precise adjustments in sympathetic and parasym-
pathetic activity that ensure appropriate changes in blood flow are
made to meet the metabolic demands of working muscle. Given
that the EPR originates in skeletal muscle and is likely affected by
the degenerative processes that occur withMD, it is logical to sug-
gest that this reflex could contribute to or exacerbate autonomic
dysfunction during exercise in this disease.
THE SKELETAL MUSCLE EXERCISE PRESSOR REFLEX
The EPR consists of two relatively distinct components. The
afferent fibers of the first, termed the muscle mechanoreflex, con-
sist predominately of thinly-myelinated group III (Aδ) neurons
that terminate within collagen tissue between skeletal fibrocytes
(Andres et al., 1985; Kaufman and Forster, 1996). Receptors acti-
vating these afferents are largely stimulated by changes in intra-
muscular pressure as well as themechanical distortion of themus-
cle during contraction (Stebbins et al., 1988; Williamson et al.,
1994). As such, the afferents respond immediately (within 2–5 s)
at the onset of physical activity (Kaufman et al., 1983). The associ-
ated receptors are not well defined butmay includemechanogated
potassium channels, L and T-type calcium channels and/or
mechanogated cation channels (Hamill and McBride, 1996). The
muscle metaboreflex is the second functional component of the
EPR. The afferent fibers of this reflex are primarily composed of
unmyelinated Group IV (C) neurons that terminate in the walls of
capillaries, venules, and lymphatic vessels within skeletal muscle
(Andres et al., 1985; Kaufman and Forster, 1996). These receptors
are chemically-sensitive and stimulated by the metabolites pro-
duced during muscle work (Kniffki et al., 1978). As a result, acti-
vation of afferent fibers associated with these receptors is some-
what delayed (5–20 s) requiring sufficient time for the production
and accumulation of chemical by-products by skeletal myocytes
(Kaufman et al., 1983; Mense and Stahnke, 1983). Several chem-
icals have been shown to activate the metaboreflex including,
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but not limited to, lactic acid, potassium, bradykinin, diproto-
nated phosphate, analogs of adenosine triphosphate (ATP) and
by-products of arachidonic acid metabolism (Rybicki et al., 1984;
Stebbins and Longhurst, 1985; Rotto et al., 1989, 1990; Sinoway
et al., 1994; Li et al., 2008). In addition, several receptors have
been implicated in mediating activation of associated afferent
fibers such as the ATP-gated ion-channel receptor (P2X3), the
acid-sensing ion channel receptor (ASIC), the bradykinin recep-
tor (B2), the transient receptor potential vanilloid 1 receptor
(TRPv1), and the cannabinoid receptor (CB1) to name a few
(Pan et al., 1993; Hanna et al., 2002; Li et al., 2004a; Williams
et al., 2008; Smith et al., 2010). It should be noted that both
groups of afferent fibers display a degree of polymorphism
with some Group III neurons responding to chemical stimuli
and some Group IV neurons responding to mechanical stimuli
(Kaufman and Forster, 1996). In addition, evidence suggests that
mechanically-sensitive afferents can be sensitized by metabolites
(especially in the presence of low perfusion) whereas the activity
of chemically-sensitive neurons is augmented during periods of
muscle ischemia (Kaufman et al., 1984b).
Most group III and IV neurons first synapse in the dorsal horn
of the spinal cord in Rexed’s laminae I, II, V, and X with addi-
tional evidence suggesting dense projections to lamina VI in the
rostral portion of the spinal cord (Kalia et al., 1981; Panneton
et al., 2005). Several neurotransmitters and peptides are involved
in conducting and modulating EPR signals in the spinal cord
including glutamate, aspartate, substance P, and nitric oxide for
example (Wilson et al., 1993; Hand et al., 1996; Li and Mitchell,
2002). Likewise, a number of receptors within the spinal cord
are involved in this process to variable degrees including, but
not limited to, NMDA receptors, non-NMDA receptors, NK-1
receptors, and P2X receptors (Wilson, 2000). Although not com-
pletely defined, from the dorsal horn muscle afferents travel along
the dorsolateral sulcus and ventral spinal cord projecting to the
cuneate nucleus, the nucleus tractus solitarius (NTS), the lat-
eral reticular nucleus, the caudal ventrolateral medulla (CVLM),
and the rostral ventrolateral medulla (RVLM) in the brain stem
(Iwamoto et al., 1984; Kozelka and Wurster, 1985; Dykes and
Craig, 1998; Potts et al., 2002). Evidence suggests that the pri-
mary processing center for this afferent information is within the
NTS although several other areas may also contribute includ-
ing the CVLM, RVLM, the lateral tegmental field, the nucleus
ambiguus and the rostral periaqueductal gray (Iwamoto et al.,
1982; Iwamoto and Kaufman, 1987; Person, 1989; Li et al., 1997;
Ishide et al., 2000; Li and Mitchell, 2000). From the brain-
stem, parasympathetic preganglionic neurons with origins in the
nucleus ambiguus travel to postganglionic neurons within the
walls of the heart (Mendelowitz, 1999). Stimulation of the EPR
decreases the activity of vagal motor neurons which serves to
increase heart rate. Sympathetic premotor neurons project from
the brainstem to preganglionic sympathetic neurons in the inter-
mediolateral cell columns of the spinal cord which synapse in
the paraveterbral chain ganglia. Transmission of this sympathetic
signal continues to postganglionic neurons that innervate the
heart and vasculature (Dampney et al., 2003). When activated,
the EPR increases sympathetic nerve activity to the heart increas-
ing its rate and contractile ability resulting in augmentations
in cardiac output. Likewise, sympathetic activity to the arte-
rial and venous circulations is concomitantly elevated mediating
vasoconstriction. In short, the EPR induces autonomic adjust-
ments to exercise by increasing sympathetic activity and largely
withdrawing parasympathetic activity.
Key factors influence the magnitude of the autonomic and
cardiovascular adjustments mediated by the EPR. For exam-
ple, the type of muscle contraction performed effects the reflex
responses produced. In general, relative tetanic contraction of
skeletal muscle (e.g., static exercise) evokes a much larger increase
in sympathetic activity, blood pressure, and heart rate than rhyth-
mic contraction (e.g., dynamic exercise) (Perez-Gonzalez, 1981;
Kaufman et al., 1984a). In addition, the greater tension developed
in the muscle, the greater the expression of the EPR (Iwamoto
and Botterman, 1985). The amount of muscle mass engaged like-
wise impacts the size of the response. In animals and humans, it
has been demonstrated on several occasions that the larger the
muscle mass contracted, the larger the sympathetically-mediated
cardiovascular response elicited (McCloskey and Steatfield, 1975;
Iwamoto and Botterman, 1985; Iellamo et al., 1999). The fiber
type of the skeletal muscle contracted also plays a role in deter-
mining the size of the evoked response. A seminal study in rabbits
has demonstrated that the experimental conversion of the pre-
dominately glycolytic gastrocnemius muscle to a more oxidative
fiber type significantly effects the expression of the EPR (Wilson
et al., 1995). In the investigation, contraction of the converted gas-
trocnemius muscle did indeed elicit elevations in blood pressure.
However, these elevations were smaller in magnitude than those
evoked by contraction of the un-converted gastrocnemius mus-
cle. Thus, although contraction of Type I slow-twitch oxidative
fibers increases blood pressure it does so to a lesser extent than
contraction of Type II fast-twitch glycolytic fibers.
EXERCISE PRESSOR REFLEX DYSFUNCTION IN DISEASE
There is precedent for development of EPR dysfunction with
the pathogenesis of disease. For example, abnormalities in EPR-
mediated autonomic control have been described in hyperten-
sion. Using a rat model of essential hypertension, it has been
demonstrated on several occasions that preferential stimulation
of the EPR elicits augmented elevations in heart rate and blood
pressure resulting from exaggerated increases in sympathetic
activity (Smith et al., 2006; Mizuno et al., 2011a,b). Further
research has delineated that this autonomic sympathetic dysfunc-
tion is mediated by overactivity of both functional components of
the EPR (i.e., the muscle mechanoreflex and metaboreflex) (Leal
et al., 2008). The mechanisms underlying EPR overactivity in this
model of hypertension remain relatively unclear although current
evidence suggests that abnormalities in the expression and/or sen-
sitivity of skeletal muscle mechanoreceptors and/or metaborecep-
tors may contribute significantly. Blockade of mechanoreceptors
with the trivalent lanthanide gadolinium substantially mitigates
the abnormally enhanced increases in sympathetic activity, blood
pressure, and heart rate in response to EPR stimulation in hyper-
tensive rats (Mizuno et al., 2011b). Likewise, antagonism of the
TRPv1 receptor (associated with the muscle metaboreflex) with
capsazepine has similar effects (Mizuno et al., 2011a). TRPv1
protein expression has also been reported to be upregulated in
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the dorsal root ganglia subserving the afferent fibers of the EPR
(Mizuno et al., 2011a). Alterations in the central processing of
EPR afferent information may also contribute. Recent studies
have shown that blocking nitric oxide production in the NTS
(nitric oxide normally serves to buffer EPR activity) of normoten-
sive rats recapitulates the mechanoreflex overactivity manifest in
hypertensive animals (Leal et al., 2012). In contrast, pharma-
cologically increasing nitric oxide production within the NTS
of hypertensive rats abrogates mechanoreflex dysfunction (Leal
et al., 2013). As a corollary finding, neuronal nitric oxide syn-
thase expression (the enzyme responsible for producing nitric
oxide) has been shown to be reduced in areas of the NTS excited
by skeletal muscle reflex input in hypertensive animals (Murphy
et al., 2013). Collectively, these studies suggest that the develop-
ment of both central (brainstem) and peripheral (skeletal muscle)
abnormalities contribute to EPR mediated autonomic dysfunc-
tion in essential hypertension. Interestingly, EPR dysfunction has
been similarly described in other models of this disease such as
prenatally programmed hypertension and angiotensin II induced
hypertension (Koba et al., 2013; Mizuno et al., 2013). With regard
to the latter, increases in oxidative stress within the skeletal muscle
have been shown to evoke EPR overactivity suggesting yet another
peripheral mechanism by which this reflex may become dysfunc-
tional (Koba et al., 2013). Perhaps most importantly, exaggera-
tions in EPR activity (specifically the metaboreflex) have recently
been described in hypertensive patients verifying the pathogene-
sis of this disorder in humans (Sausen et al., 2009; Delaney et al.,
2010). Reports demonstrating that hypertensive individuals have
a larger percentage of Type II skeletal muscle fibers as compared to
Type I likely contributes significantly to the development of EPR
overactivity in these patients (Juhlin-Dannfelt et al., 1979).
It is well established that chronic hypertension can induce
pathological hypertrophic cardiac remodeling leading to heart
failure (Takimoto et al., 2005). Given this interrelationship, it is
not surprising that autonomic regulation by the muscle reflex is
likewise abnormal in this disease (Piepoli et al., 1999;Middlekauff
et al., 2000; Negrao et al., 2001). For example, several studies have
demonstrated that preferential stimulation of the EPR in rats with
dilated cardiomyopathy evokes exaggerated increases in sympa-
thetic activity resulting in abnormally large elevations in heart
rate and blood pressure (Smith et al., 2003; Koba et al., 2008).
What is surprising, however, is that the etiology of EPR overactiv-
ity in heart failure appears to be different than in hypertension.
As described previously, in hypertension both the mechanically
and chemically sensitive components of the EPR are inappro-
priately augmented. In heart failure, evidence in both animals
and humans suggests that EPR overactivity is primarily driven
by potentiation of the mechanoreflex whereas metaboreflex func-
tion may be blunted (Sterns et al., 1991; McClain et al., 1993;
Middlekauff et al., 2001; Wang et al., 2010). With regard to the
mechanoreflex, selective activation of muscle mechanoreceptors
elicits enhanced increases in sympathetic activity (Li et al., 2004b;
Smith et al., 2005a; Wang et al., 2010). Research suggests this may
be due to a sensitization of the mechanoreceptors by the metabo-
lites produced duringmuscle contraction (Middlekauff and Chiu,
2004; Gao et al., 2007; Koba et al., 2010; Wang et al., 2010). In
support of this tenet, blockade of the B2 bradykinin receptor
as well as the ATP P2X3 receptor attenuates the cardiovascular
response to EPR and mechanoreflex activation to a greater extent
in cardiomyopathic rats as compared to healthy controls (Koba
et al., 2010; Wang et al., 2010). Further, P2X3 protein expression
is enhanced in the dorsal root ganglion subserving mechano-
sensitive afferents in heart failure animals (Gao et al., 2007; Wang
et al., 2010). Similarly, antagonizing the enzyme cyclo-oxygenase
2 (COX-2), responsible for the production of prostaglandins from
arachidonic acid, reduces the sympathetic response to stimula-
tion of the mechanoreflex to a larger degree in heart failure rats
and patients than in healthy controls (Middlekauff et al., 2008;
Morales et al., 2012). COX-2 protein expression is likewise ele-
vated in skeletal muscle of cardiomyopathic rats (Morales et al.,
2012). In contrast, the cardiovascular response to administration
of metaboreceptor agonists is attenuated in heart failure (Li et al.,
2004b; Smith et al., 2005b). Interestingly, mRNA and protein
expression for the TRPv1 receptor (a marker of chemically-
sensitive group IV afferent fibers) is reduced in both the dorsal
root ganglion and soleus muscle of heart failure rats (Smith et al.,
2005b; Wang et al., 2010). Moreover, selective ablation of group
IV afferent neurons in healthy rats has been shown to recapit-
ulate the EPR overactivity that develops in heart failure (Smith
et al., 2005b). These findings suggest that the withdrawal and/or
de-sensitization of chemically-sensitive afferent fibers may con-
tribute to the EPR dysfunction that manifests in heart failure but
do not themselves drive the reflex’s overactivity. These changes
may occur as a result of the skeletal myopathy (conversion from
Type I to Type II skeletal muscle fibers, skeletal muscle atro-
phy, compromised oxidative capacity) known to develop with the
pathogenesis of heart failure (Lipkin et al., 1988). Increases in
oxidative stress within skeletal muscle have likewise been impli-
cated in the generation of EPR overactivity in this disease and
may play an important role in the differential mechanoreflex and
metaboreflex dysfunction that manifests (Koba et al., 2009).
EXERCISE PRESSOR REFLEX DYSFUNCTION IN MUSCULAR
DYSTROPHY?
Whether the EPR is abnormal in MD as it is in hypertension
and heart failure remains to be determined. To our knowledge,
there have been no studies conducted examining the function
of this reflex in the muscular dystrophies. That being stated,
clearly the functional anatomy of the EPR as well as the patho-
physiology it displays in cardiovascular disease demonstrates its
susceptibility to dysfunction with the advent of MD. In sup-
port of this concept, other causes of muscle degeneration such
as disuse atrophy have been shown to alter muscle reflex func-
tion in both animals and humans (Kamiya et al., 2004; Hayashi
et al., 2005). Further, a number of documented alterations that
manifest with MD have the potential to directly influence EPR
function. For example, similar to heart failure, increased expres-
sion of COX-2 and P2X protein has been demonstrated in skeletal
muscle of mdx mice (Yeung et al., 2006; de Oliveira et al., 2013).
As in both hypertension and heart failure, studies suggest that
oxidative stress is likewise enhanced within skeletal muscle in
MD and may also be increased in the brain; the latter of which
could potentially affect central EPR processing (Kaczor et al.,
2007; Sabharwal and Chapleau, 2014). As previously discussed,
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functional sympatholysis has been shown to be impaired in MD
producing muscle ischemia during exercise (Thomas et al., 1998).
As a result, removal of exercise-induced metabolites is likely com-
promised. This could potentially sensitize mechanically-sensitive
afferent neurons (perhaps through P2X and COX-2 pathways as
in heart failure) and/or augment the activity of metabolically-
sensitive sensory fibers. Collectively, these changes would favor
the generation of EPR overactivity. Such overactivity could be
produced by the pathogenesis of EPR dysfunction or simply
evoked by overstimulation of a normally operating reflex dur-
ing ischemic exercise. Changes in muscle mass could also play
a significant role. As previously stated, in general MD produces
widespread and profound muscle atrophy (Kornegay et al., 2012).
A loss of functional muscle mass would be expected to decrease
expression of the EPR. That being stated, somemuscle is spared in
most forms of the disease and, in certain variations, a paradoxical
hypertrophy often develops in select muscles (e.g., gastrocnemius
in Duchenne and Becker MD) (Kornegay et al., 2012). As such,
expression of the reflex would likely be dependent on the mus-
cle being contracted and the extent to which it had been affected
by the disease process. Unlike hypertension and heart failure,
Type II fast-twitch fibers have been shown to be preferentially
affected by the dystrophic process in certain forms of MD (e.g.,
Duchenne MD, facioscapulohumeral MD) displaying the earli-
est and most pronounced deterioration (Pedemonte et al., 1999;
D’Antona et al., 2007). Type I slow-twitch fibers are affected sec-
ondarily and there is often a shift from fast-twitch to slow-twitch
fibers (Webster et al., 1988; D’Antona et al., 2007). This too would
be expected to depress EPR activity. Similarly, given the structural
myocyte defects that develop with MD, it is possible that skele-
tal muscle innervation by Group III and IV sensory neurons is
compromised in the disease. To date, little is known with regard
to this possibility although motor innervation of the muscle has
been shown to display longitudinal displacement with some axons
ending freely in connective tissue rather thanmuscle fibers (Coers
and Telerman-Toppet, 1977). It should be noted that the function
of Group I and II sensory afferents (e.g., muscle spindles) appears
to be preserved inMD (Aimonetti et al., 2005). Whether the same
is true of Group III and IV fibers remains to be determined. A the-
oretical depiction of the factors that could affect EPR activity in
MD is presented in Figure 1.
Although largely speculative at this point, alterations in EPR-
mediated autonomic function in MD could significantly impact
the progression of the disease. Again, metabolic modulation of
sympathetically-mediated vasoconstriction during exercise is sig-
nificantly diminished in certain forms ofMD (i.e., impaired func-
tional sympatholysis). This inability to buffer α-adrenergic vaso-
constriction within the skeletal muscle would only be exacerbated
by EPR-mediated exaggerations in sympathetic activity. This may
contribute to the muscle ischemia that develops during exercise in
these patients promoting tissue degeneration. Likewise, enhanced
sympathetic activity to the heart evoked by the EPR could increase
the risk for arrhythmogenesis, ventricular arrhythmia, and sud-
den death. As evidence, it has been demonstrated in rats that
experimentally increasing sympathetic input to the heart can
produce lethal cardiac arrhythmias (Oppenheimer et al., 1991).
Prolonged EPR dysfunction could also play a significant role in
the development of the cardiomyopathy that is a common clin-
ical feature in many muscular dystrophies. Conversely, if EPR
function is diminished in MD, as is its metabolic component in
heart failure, the prognosis for EPR-induced pathology may be
similar although the mechanisms slightly different. Decreases in
EPR function could prevent the normal vasoconstrictor responses
that occur in vascular beds not involved with exercise (e.g., vis-
ceral organs, non-exercising skeletal muscle). Vasoconstriction
in these beds is important for re-directing blood flow to active
skeletal muscle. The net effect of such an occurrence would be
much the same as when the EPR is overactive; the development of
ischemia in exercising muscle. This inability to increase sympa-
thetic activity to the heart could likewise prevent augmentations
in cardiac output needed to support the adequate delivery of
blood to the working muscle. It might also increase the risk for
the development of bradyarrythmias which have been described
in some forms of MD (e.g., myotonic dystrophy type 1) (Aminoff
et al., 1985). Undoubtedly, there is a significant need for research
designed to address these possibilities.
EXERCISE TRAINING IN MUSCULAR DYSTROPHY
The benefits of exercise training are numerous and include
strengthening of skeletal muscle. In addition, training has been
shown to improve autonomic function in disease states in which
skeletal myopathy develops. For example, aerobic exercise train-
ing has been shown to markedly improve autonomic regulation
by the EPR in heart failure (Wang et al., 2012a,b). Clearly,
MD patients would benefit from improvements in both muscle
strength and autonomic function. However, due to the progres-
sive degenerative nature of the skeletal myopathy that is the
hallmark feature of muscular dystrophy, patients often remain
relatively sedentary and are, on many occasions, counseled to
avoid excess physical activity (Sveen et al., 2008). The rationale
underlying this prescription of non-exercise is the increased prob-
ability of exercise-induced muscle damage which may accelerate
the progression of the disease (Petrof, 1998). That being stated,
several reports suggest that, under the right conditions, exercise
can evoke beneficial effects in certain forms of MD. For example,
low intensity exercise training in mdx mice (treadmill running
at 9m/min) has been shown to reduce muscle damage caused
by lipid and protein oxidation (Kaczor et al., 2007). In patients
with Becker MD, 12 weeks of cycling exercise at 65% maximal
oxygen uptake (VO2max) has been shown to improve strength
in cycling muscles as well as VO2max without increasing markers
of skeletal muscle damage (Sveen et al., 2008). Similar beneficial
effects of cycling exercise without concomitant muscle injury have
been reported in patients with facioscapulohumeral MD (Olsen
et al., 2005), myotonic dystrophy (Orngreen et al., 2005), and
limb-girdle type 2I MD (Sveen et al., 2007). Likewise both low
and high intensity resistance training (knee extension, elbow flex-
ion) have been shown to increase muscle strength and endurance
while being largely well tolerated in both Becker and limb-girdle
type 2 MD patients (Sveen et al., 2013). Collectively, these find-
ings suggest that regular, supervised exercise training may be a
safe beneficial therapeutic modality to use in the management
of MD patients that maintains the potential to increase daily
function. However, the prescription of exercise in MD remains
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FIGURE 1 | Theoretical model of factors that could influence exercise
pressor reflex function in muscular dystrophy. During muscle
contraction, the exercise pressor reflex is engaged upon stimulation of
receptors which activate mechanically and metabolically sensitive
afferent fibers innervating skeletal muscle. Sensory signals from these
fibers are processed within autonomic control centers in the brainstem
evoking decreases in parasympathetic nerve activity to the heart and
increases in sympathetic nerve activity to the heart, adrenal gland, and
vasculature of skeletal muscle, kidneys, and the splanchnic region.
Numerous changes that occur with the pathogenesis of muscular
dystrophy maintain the potential to both enhance and depress exercise
pressor reflex activity. EPR, exercise pressor reflex; MD, muscular
dystrophy; PSNA, parasympathetic nerve activity; SNA, sympathetic nerve
activity.
controversial and warrants additional investigation. Perhaps, as
has been hypothesized, there may be a threshold of exercise
intensity that demarks a positive therapeutic intervention from
a deleterious activity that hastens pathology (Kaczor et al., 2007).
If further research determines that changes in EPR activity con-
tributes to and/or exacerbates autonomic dysfunction in MD,
this factor must be taken into account as well when prescribing
exercise.
SUMMARY
The muscular dystrophies are a group of muscle-wasting disor-
ders that reduce quality of life and often lead to premature death.
In addition to skeletal muscle, MD is known to deleteriously
alter cardiac function in many forms of the disease. Recent evi-
dence suggests that, although not the primary cause, abnormal
regulation of the autonomic nervous system may contribute to
the development of cardiac conduction anomalies as well as car-
diomyopathy in MD. It has been postulated that such autonomic
dysfunction may likewise be a causative factor in the progres-
sion of skeletal myopathy in this disease. The EPR is intimately
involved in mediating the autonomic adjustments necessary to
ensure the proper delivery of blood to working skeletal muscle.
Given that this reflex originates in skeletal muscle, it may be vul-
nerable to the development of dysfunction in MD. MD-induced
alterations in EPR function could compromise the reflex’s abil-
ity to adequately increase blood flow to skeletal muscle during
physical activity producing ischemia. Repeated bouts of ischemia
during exercise could initiate and/or accelerate muscle degener-
ation in MD patients. Precedence for the pathogenesis of EPR
dysfunction has been established in both hypertension and heart
failure (a disease state often accompanied by significant skeletal
myopathy) lending support to the tenet that EPR dysfunctionmay
likewise develop in MD.
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